Evaluation of the efficacy of convalescent plasma in moderate to severe COVID-19 during 2020-2021: a retrospective observational study
Submitted: May 5, 2024
Accepted: October 18, 2024
Published: December 20, 2024
Accepted: October 18, 2024
Abstract Views: 146
PDF_EARLY VIEW: 24
SUPPLEMENTARY MATERIAL: 5
SUPPLEMENTARY MATERIAL: 5
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Francesco Orso, Riccardo Barucci, Stefania Fracchia, Giulio Mannarino, Alessandra Pratesi, Francesco Fattirolli, Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used , Monaldi Archives for Chest Disease: Vol. 80 No. 4 (2013): Cardiac Series
- Gian Francesco Mureddu, Stefano Nistri, Anna Maria Gori, Pompilio Faggiano, Biagio Fimiani, Antonio Maggi, Gianfranco Misuraca, Massimo Uguccioni, Luigi Tavazzi, Giovanni Battista Zito, Awareness and appropriateness of the management of preclinical heart failure in outpatient clinics in Italy: Insights from the VASTISSIMO study - EValuation of the AppropriateneSs of The preclInical phase (Stage A and Stage B) of Heart FaIlure Management in Outpatient Clinics in Italy , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
- Kartik Deshmukh, Arjun Khanna, Single inhaler triple therapy in COPD – all that glitters is not gold , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Matteo Bonini, Paolo Palange, Roflumilast is safe and effective in improving symptoms and lung function in severe COPD , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Unnati Desai, Saby AK, Ketaki Utpat, Jyoti Bacche, Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis , Monaldi Archives for Chest Disease: Early Access
- Madalina Macrea, Richard ZuWallack, Linda Nici, There’s no place like home: Integrating pulmonary rehabilitation into the home setting , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
- Vera Auchynka, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Varvara Solodovnikova, Dzmitry Katovich, Svetlana Setkina, Askar Yedilbayev, Aliaksandr Skrahin, Alena Skrahina, Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Martina Rafanelli, Andrea Ungar, High blood pressure and syncope: orthostatic hypotension as a link , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Stefania Angela Di Fusco, Furio Colivicchi, Nadia Aspromonte, Marco Tubaro, Alessandro Aiello, Massimo Santini, Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Nidal Tourkmani, Treatment and management of advanced heart failure in elderly , Monaldi Archives for Chest Disease: Vol. 89 No. 1 (2019)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
You may also start an advanced similarity search for this article.